Patel Dhruvkumar M, Patel Maitri M, Patel Lalitkumar B, Patel Vahin B, Patel Mukundkumar V, Patel Dhara K
Department of Internal Medicine, Louisiana State University, Shreveport, LA, USA.
Department of Internal Medicine, GCS Medical College, Gujarat Cancer and Research Institute, Ahmedabad, India.
Curr Drug Saf. 2025;20(4):509-513. doi: 10.2174/0115748863324787240916114833.
Although diuretic-induced Acute Pancreatitis (AP) cases are typically mild to moderate, severe and potentially fatal occurrences can arise. Case Series and Literature Review: We have, herein, presented a series of diuretic-induced AP cases from March 2018 to February 2024 of a 54-year-old woman treated with chlorthalidone, a 45-year-old male treated with hydrochlorothiazide, and a 48-year-old male treated with frusemide. The literature search has identified 26 cases published to date, 10 from frusemide and 16 from thiazide diuretics. The Naranjo adverse reaction probability scale has categorized all three drugs as "probable". All cases have responded to conservative treatment and cessation of the offending drug. Various mechanisms, such as hypersensitization, ischemia, direct cytotoxic effects, hypercalcemia, and dose-dependent idiosyncrasy, have been found to lead to intrapancreatic activation of pancreatic enzymes, resulting in drug-induced AP.
Further research into the mechanisms and genetic factors contributing to diureticinduced AP is essential for enabling early diagnosis and management of diuretic-induced AP.
尽管利尿剂诱发的急性胰腺炎(AP)病例通常为轻至中度,但也可能出现严重且有潜在致命风险的情况。病例系列与文献综述:在此,我们呈现了一系列2018年3月至2024年2月期间因利尿剂诱发AP的病例,其中包括一名接受氯噻酮治疗的54岁女性、一名接受氢氯噻嗪治疗的45岁男性以及一名接受呋塞米治疗的48岁男性。文献检索发现,迄今为止已发表了26例病例,其中10例由呋塞米诱发,16例由噻嗪类利尿剂诱发。Naranjo不良反应概率量表将这三种药物均归类为“很可能”。所有病例经保守治疗及停用致病药物后均有反应。已发现多种机制,如超敏反应、缺血、直接细胞毒性作用、高钙血症和剂量依赖性特异反应,可导致胰腺内胰酶激活,从而引发药物性AP。
进一步研究导致利尿剂诱发AP的机制和遗传因素对于早期诊断和管理利尿剂诱发的AP至关重要。